Quarterly compliance certificate for share dematerialisation filed with BSE

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹113.25

prior close

₹112.45

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.8%+2.1% vs market

Healthcare Service Provider peers, median of 27sector-1.8%+1.1% vs sector

On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 1.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7-2.8+2.1-1.8+1.1

Next day

+1.5-2.5+4.0-0.7+2.3

-3.5-1.7-1.9-0.2-3.3

-7.3-1.5-5.8-1.8-5.5

+6.3-0.8+7.1+0.2+6.1

+2.0-2.4+4.5-2.7+4.7

+1.5-3.4+4.9-5.5+7.0

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aspira Pathlab submitted a routine quarterly compliance certificate to BSE under SEBI regulation 74(5) for the quarter ended September 30, 2026. Its registrar MUFG Intime India confirmed processing of share dematerialisation requests received from depository participants during the quarter, with physical certificates cancelled and depositories recorded as registered owners. This is a standard procedural filing.

Likely market impact

Routine procedural compliance with SEBI rules. No material effect on shareholders or the share price.